Comparable stake leader
Squadron Capital Management LLC
SEC ownership of Lipocine Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001535955.
Disclosed value leader
Squadron Capital Management LLC
Comparable rows
36/46
Latest evidence
03 Aug 2026
- Public ticker
- LPCN on Nasdaq
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Squadron Capital Management LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
36 of 46
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Squadron Capital Management LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
03 Aug 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001535955
- Issuer location
- Salt Lake City, United States
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Lipocine Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Squadron Capital Manageme...
Disclosed value leader
Squadron Capital Manageme...
Comparable rows
36/46
Latest evidence
03 Aug 2026
13D/G
13F
3/4/5
Lead comparable stake: 9.8%
10 rows are not safely comparable across share classes.
13D/G row: Squadron Capital Management LLC
Showing 1-8 of 46 holder rows.
Quick read
Squadron Capital Management LLC leads the comparable SEC ownership view at 9.8%.
36 of 46 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Squadron Capital Management LLC's linked filing trail.
Comparable ownership
Top 5
Squadron Capital Management LLC
9.8%
Ikarian Capital, LLC
6.3%
Eversept Partners, LP
3.6%
VANGUARD CAPITAL MANAGEMENT LLC
2.8%
ACADIAN ASSET MANAGEMENT LLC
2.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 46 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Squadron Capital Management LLC |
13D/G
13F
Squadron Master Fund LP · Company
|
9.8%
|
$2,079,432
810,000 shares
|
+$924,192 | 30 Jun 2026 |
| Ikarian Capital, LLC |
13F
13D/G
Company
|
6.3%
from 13D/G
|
$1,301,902
508,556 shares
|
— | 30 Jun 2026 |
| Eversept Partners, LP |
13F
Company
|
3.6%
|
$755,172
294,989 shares
|
— | 30 Jun 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
2.8%
|
$590,907
230,823 shares
|
— | 30 Jun 2026 |
| ACADIAN ASSET MANAGEMENT LLC |
13F
Company
|
2.1%
|
$435,000
170,417 shares
|
— | 30 Jun 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
Company
|
1.7%
|
$359,647
140,487 shares
|
— | 30 Jun 2026 |
| JANE STREET GROUP, LLC |
13F
Company
|
1.2%
|
$243,781
95,227 shares
|
— | 30 Jun 2026 |
| BlackRock, Inc. |
13F
Company
|
1.1%
|
$228,536
89,272 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$384,100.
Buys
$384,100
Insiders: 2
Sells
$0
Insiders: 0
Net
+$384,100
Shares: +188,000
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 188,000
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 188,000 | 0 | $384,100 | $0 | +$384,100 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-10 of 10 reporting-owner rows connected to Lipocine Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
10
Largest Forms 3/4/5 holder
Mahesh V Patel
Net 12M change
+$384,100
Latest report
03 Aug 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Mahesh V Patel | Chief Executive Officer, Director | $1,787,522 | +$50,750 | +2.9% | Mixed | 29 Jun 2026 |
| John W. Higuchi | Director | $450,590 | +$333,350 | +284% | Mixed | 03 Jun 2026 |
| Krista Fogarty | Principal Accounting Officer | $168,613 | Mixed | 18 Dec 2025 | ||
| Morgan R. Brown | Chief Financial Officer | $46,746 | Mixed | 07 Dec 2021 | ||
| Richard Dana Ono | Director | $36,883 | Mixed | 03 Jun 2026 | ||
| Jeffrey Arvin Fink | Director | $36,883 | Mixed | 04 Jun 2025 | ||
| George Nomikos | Chief Medical Officer | $33,200 | Mixed | 01 Nov 2022 | ||
| Spyros Papapetropoulos | Director | $22,956 | Mixed | 04 Jun 2025 | ||
| Jill M. Jene | Director | $22,956 | Mixed | 03 Jun 2026 | ||
| Michael Grissinger | Director | Mixed | 03 Aug 2026 |
Recent insider transactions for Lipocine Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Michael Grissinger | LPCN | Stock Option (Right to Buy) | Award | 2,000 | 2,000 | 03 Aug 2026 | Direct | |||
| Mahesh V Patel | LPCN | Stock Option (Right to Buy) | Award | 30.3% | 52,781 | 227,214 | 29 Jun 2026 | Direct | ||
| John W. Higuchi | LPCN | Common Stock (Right to Buy) | Award | 15.3% | 1,764 | 13,290 | 03 Jun 2026 | Direct | ||
| Jill M. Jene | LPCN | Stock Option (Right to Buy) | Award | 24.6% | 1,764 | 8,938 | 03 Jun 2026 | Direct | ||
| Richard Dana Ono | LPCN | Common Stock (Right to Buy) | Award | 15.3% | 1,764 | 13,290 | 03 Jun 2026 | Direct | ||
| John W. Higuchi | LPCN | Common stock | Purchase | 24.4% | $81,200 | $2.03 | 40,000 | 203,797 | 07 Apr 2026 | Direct |
| John W. Higuchi | LPCN | Common stock | Purchase | 301.5% | $252,150 | $2.05 | 123,000 | 163,797 | 06 Apr 2026 | Direct |
| Mahesh V Patel | LPCN | Common stock | Purchase | 18.4% | $50,750 | $2.03 | 25,000 | 160,679 | 06 Apr 2026 | Direct |
| Mahesh V Patel | LPCN | Common stock | Purchase | 22.6% | 25,000 | 135,679 | 02 Apr 2026 | Direct | ||
| Mahesh V Patel | LPCN | Stock Option (Right to Buy) | Award | 15.9% | 25,000 | 182,668 | 02 Jan 2026 | Direct | ||
| Mahesh V Patel | LPCN | Stock Option (Right to Buy) | Award | 5.79% | 8,629 | 157,668 | 18 Dec 2025 | Direct | ||
| Krista Fogarty | LPCN | Stock Option (Right to Buy) | Award | 107.4% | 20,786 | 40,146 | 18 Dec 2025 | Direct |
* marks a reported price that did not pass the local price check.